Liang Chu Selected Research

Liang Chu Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 05/2004
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2004
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
5	Sepsis (Septicemia) 01/2021 - 08/2016
4	Carcinogenesis 01/2020 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 01/2019
2	Infections 01/2021 - 08/2016
2	Cardiomyopathies (Cardiomyopathy) 05/2020 - 12/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2012
2	Cholangiocarcinoma 01/2020 - 11/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2017
2	Lung Neoplasms (Lung Cancer) 03/2017 - 05/2015
1	COVID-19 07/2021
1	Atherosclerosis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Heart Injuries 05/2020
1	Cataract (Cataracts) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Pre-Eclampsia (Preeclampsia) 01/2020
1	Dizziness (Lightheadedness) 12/2019
1	Cardiotoxicity 01/2019

Drug/Important Bio-Agent (IBA)

7	Therapeutic UsesIBA 01/2021 - 09/2014
5	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2016
5	Small Nucleolar RNA (snoRNA)IBA 01/2022 - 08/2012
4	CystatinsIBA 01/2021 - 05/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2004
4	LigandsIBA 05/2015 - 05/2004
3	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2020
3	CytokinesIBA 01/2021 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 05/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2017
3	CaspasesIBA 09/2012 - 05/2004
2	6-methyladenineIBA 05/2022 - 03/2022
2	N-methyladenosineIBA 05/2022 - 03/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 08/2016
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2018
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2018
2	Biological ProductsIBA 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2019
2	InterleukinsIBA 01/2019 - 09/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2009 - 06/2008
1	Glycyrrhetinic Acid (Po 12)IBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Nucleic AcidsIBA 07/2021
1	AntibodiesIBA 07/2021
1	Recombinant ProteinsIBA 01/2021
1	Protein Phosphatase 1IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	OsteoprotegerinIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 05/2020
1	MyoglobinIBA 05/2020
1	Myeloid Differentiation Factor 88IBA 05/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2020
1	pro-brain natriuretic peptide (1-76)IBA 05/2020
1	Troponin IIBA 05/2020
1	EnzymesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Cortisone FDA Link 01/2020
1	epsilon receptor (receptor, epsilon)IBA 01/2020
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2020
1	Protein Tyrosine PhosphatasesIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2019
1	Indicators and Reagents (Reagents)IBA 02/2019
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 02/2019
1	UbiquitinIBA 02/2019
1	Ligases (Synthetase)IBA 02/2019
1	Heme Oxygenase-1IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	dioscinIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Glycogen Synthase (Synthase I)IBA 01/2019
1	CateninsIBA 01/2019
1	AgarIBA 11/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2018

Therapy/Procedure

8	Therapeutics 01/2019 - 05/2004
4	Ligation 01/2021 - 08/2016
4	Punctures 01/2021 - 08/2016
2	Immunotherapy 05/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 08/2012
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2021
1	Immunomodulation 01/2021
1	Craniotomy 12/2019
1	Oncolytic Virotherapy 01/2019